BDBM272899 (S)-2-((1-(2- aminobenzo[d]oxazol- 5-yl)-7,8,9,10- tetrahydro-6-oxa- 2,10a- diazacycloocta[cd]- inden-4- yl)oxy)propanamide::US10065970, Compound 204
SMILES: C\C=C(\O[C@@H](C)C(N)=O)/C=c1/nc(-c2ccc3oc(N)nc3c2)n2CCCCO/C=c/1\2
InChI Key: InChIKey=RJCFCNNTQDCDRA-ZGYCTTSVSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens (Human)) | BDBM272899 ((S)-2-((1-(2- aminobenzo[d]oxazol- 5-yl)-7,8,9,10-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <0.0200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description PI3K Binding assays are intended for determining the biochemical potency of small molecule PI3K inhibitors. The PI3K lipid kinase reaction is perform... | US Patent US10065970 (2018) BindingDB Entry DOI: 10.7270/Q27P91FB | |||||||||||
More data for this Ligand-Target Pair |